Clinical trials
Enrolling by invitation Stomach Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 12 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Qilu Hospital of Shandong University | 3 |
| Affiliated Hospital of Jiangnan University | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Blokhin's Russian Cancer Research Center | 1 |
| Dong Peng | 1 |
| Fujian Medical University | 1 |
| Gene Solutions | 1 |
| Hospital Universitario de Gran Canaria Doctor Negrín | 1 |
| Liu Yang | 1 |
| Mahidol University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 21 |
| Breast Neoplasms | 3 |
| Carcinoma, Transitional Cell | 2 |
| Colorectal Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Anastomotic Leak | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
| Esophageal Squamous Cell Carcinoma | 1 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.